The PKCβ selective inhibitor, enzastaurin (LY317615), inhibits growth of human lymphoma cells.

被引：0
|
作者：
Rossi, RM [1 ]
Henn, AD [1 ]
Conkling, R [1 ]
Guzman, ML [1 ]
Bushnell, T [1 ]
Harvey, J [1 ]
Fisher, RI [1 ]
Jordan, CT [1 ]
机构：
[1] Univ Rochester, Sch Med, Ctr Canc, Rochester, NY USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1483
引用
收藏
页码：427A / 427A
页数：1
相关论文
共 50 条
  • [21] Enzastaurin (LY317615.HCl) suppresses signaling through the PKC and AKT pathways, inducing apoptosis, suppressing tumor-induced angiogenesis and reducing growth of human cancer xenografts
    McNulty, Ann M.
    Konicek, Bruce W.
    Lynch, Rebecca L.
    Thornton, Donald
    Douglass, Larry
    Colligan, Bruce
    Carter, Julia H.
    Graff, Jeremy R.
    CANCER RESEARCH, 2006, 66 (08)
  • [22] Enzastaurin (LY317615.HCI) suppresses signaling through the PKC and AKT pathways, inducing apoptosis, suppressing tumor-induced angiogenesis and reducing growth of human cancer xenografts
    Graff, J.
    McNulty, A.
    Parsons, S.
    Lewis, J.
    Konicek, B.
    Banks, C.
    Capen, A.
    Douglass, L.
    Carter, J.
    Starling, J.
    EJC SUPPLEMENTS, 2006, 4 (12): : 176 - 176
  • [23] The protein kinase C beta antagonist enzastaurin (LY317615.HCL) inhibits cancer cell growth by multiple mechanisms and is active in EGFR inhibitors-resistant cancer cells
    Roberto, Bianco
    Damiano, Vincenzo
    Gelardi, Teresa
    Daniele, Gennaro
    Caputo, Rosa
    Melisi, Davide
    Bianco, Angelo Raffaele
    Lahn, Michael
    Ciardiello, Fortunato
    Tortora, Giampaolo
    CANCER RESEARCH, 2006, 66 (08)
  • [24] The PKC-inhibitor enzastaurin inhibits MM cell growth, survival and migration in the bone marrow microenvironment.
    Podar, K
    Raab, MS
    Abtahi, D
    Tai, YT
    Lin, B
    Munshi, NC
    Hideshima, T
    Chauhan, D
    Anderson, KC
    BLOOD, 2005, 106 (11) : 454A - 454A
  • [25] CD40 ligand inhibits growth of canine lymphoma cells.
    Bansal, P
    MacEwen, G
    Fanslow, W
    DiPersio, JF
    BLOOD, 1997, 90 (10) : 2275 - 2275
  • [26] Selective inhibition of cyclooxygenase-2 inhibits growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza, RF
    Shewmake, K
    Beer, DG
    Cryer, B
    Spechler, SJ
    GASTROENTEROLOGY, 2000, 118 (04) : A707 - A707
  • [27] A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice
    Wu, Jing
    Liu, Shuye
    Fan, Zhijuan
    Zhang, Lei
    Tian, Yaqiong
    Yang, Rui
    TUMOR BIOLOGY, 2016, 37 (06) : 8391 - 8401
  • [28] Sensitivity of diffuse large B cell lymphoma cells to Enzastaurin (LY317615.HCl) and its primary metabolite (LY326020) is critically dependent upon disruption of the eIF4F translation initiation complex
    McNulty, Ann M.
    Dumstorf, Chad A.
    Dumstorf, Chad A.
    Parsons, Stephen H.
    Konicek, Bruce W.
    Hall, Chad A.
    Graff, Jeremy R.
    CANCER RESEARCH, 2012, 72
  • [29] Effect of the PKC β inhibitor LY 379196 in combination with growth factors on proliferation of bovine retinal vascular endothelial cells
    Lang, GE
    Lang, GK
    Baldysiak-Figiel, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U143 - U143
  • [30] Ceramide inhibits growth and induces apoptosis in human breast cancer cells.
    Zhang, C
    Schroeder, JJ
    FASEB JOURNAL, 1997, 11 (03): : 3277 - 3277
12345